Daniel J. Figdore - Concepedia

Author

Daniel J. Figdore

Mayo Clinic ORCID

Also Known As

D Figdore, D. Figdore, Dan Figdore, Dan J Figdore, Dan J. Figdore, Daniel Figdore, Daniel J Figdore, Daniel J. Figdore

Publications

446

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Florida Mayo Clinic in Arizona WinnMed Wake Forest University

About

Daniel J. Figdore is an author at Mayo Clinic specializing in neuroscience, social sciences, and neurophysiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Social Sciences	2	2	70
2	Neurology	2	2	70
3	Neuroscience	2	2	70
4	Medicine	1	1	30
5	Cognitive Neuroscience	1	1	40

Daniel J. Figdore

Publications

415

Citations

H-Index

Page 1

	Year	Citations
Predicting amyloid PET and tau PET stages with plasma biomarkers Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, Brain	2023	135
Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p‐tau217 immunoassays Daniel J. Figdore, Michael Griswold, Joshua A. Bornhorst, Alzheimer s & Dementia	2024	59
Plasma neurofilament light chain (NfL) reference interval determination in an Age-stratified cognitively unimpaired cohort Joshua A. Bornhorst, Daniel J. Figdore, Michelle R. Campbell, Clinica Chimica Acta NeuropsychologyBrain FunctionNeurophysiologyDevelopmental Cognitive NeuroscienceDementia	2022	40
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, Alzheimer s & Dementia	2024	36
Plasma biomarkers of Alzheimer's disease in the continuum of dementia with Lewy bodies Patricia Diaz‐Galvan, Scott A. Przybelski, Alicia Algeciras‐Schimnich, Alzheimer s & Dementia	2024	35
Head-to-head comparison of four plasma neurofilament light chain (NfL) immunoassays Susan Ashrafzadeh‐Kian, Daniel J. Figdore, Bethany J. Larson, Clinica Chimica Acta NeurophysiologyNeuroanatomyMedicineNeurologyBiophotonics	2024	30
Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations Joshua A. Bornhorst, Carly S. Lundgreen, Stephen D. Weigand, Neurology	2025	28
Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis Vijay K. Ramanan, Robel K Gebre, Jonathan Graff‐Radford, Brain	2023	22
Performance of the Lumipulse plasma Aβ42/40 and pTau181 immunoassays in the detection of amyloid pathology Daniel J. Figdore, Heather J. Wiste, Joshua A. Bornhorst, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2024	20
Diagnostic performance of plasma p‐tau217 and Aβ42/40 biomarkers in the outpatient memory clinic Yoav Piura, Daniel J. Figdore, Christian Lachner, Alzheimer s & Dementia	2025	10

Page 1